264 related articles for article (PubMed ID: 14962439)
1. Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia.
Jonas JB
Am J Ophthalmol; 2004 Feb; 137(2):367-8. PubMed ID: 14962439
[TBL] [Abstract][Full Text] [Related]
2. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide in sympathetic ophthalmia.
Ozdemir H; Karacorlu M; Karacorlu S
Graefes Arch Clin Exp Ophthalmol; 2005 Jul; 243(7):734-6. PubMed ID: 15756580
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
5. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
6. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
[TBL] [Abstract][Full Text] [Related]
8. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
11. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone acetonide treatment for serpiginous choroiditis.
Adigüzel U; Sari A; Ozmen C; Oz O
Ocul Immunol Inflamm; 2006 Dec; 14(6):375-8. PubMed ID: 17162609
[TBL] [Abstract][Full Text] [Related]
13. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.
Beer PM; Bakri SJ; Singh RJ; Liu W; Peters GB; Miller M
Ophthalmology; 2003 Apr; 110(4):681-6. PubMed ID: 12689886
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide for the management of diabetic papillopathy.
Al-Haddad CE; Jurdi FA; Bashshur ZF
Am J Ophthalmol; 2004 Jun; 137(6):1151-3. PubMed ID: 15183815
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
Jonas JB; Kreissig I; Degenring R
Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
[TBL] [Abstract][Full Text] [Related]
16. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA
Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
[TBL] [Abstract][Full Text] [Related]
17. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.
Jonas JB; Degenring RF; Kreissig I; Friedemann T; Akkoyun I
Eye (Lond); 2005 Feb; 19(2):163-70. PubMed ID: 15218517
[TBL] [Abstract][Full Text] [Related]
18. Short-term intraocular pressure trends after intravitreal triamcinolone injection.
Lee EW; Hariprasad SM; Mieler WF; Newman TL; Apte RS
Am J Ophthalmol; 2007 Feb; 143(2):365-7. PubMed ID: 17258540
[TBL] [Abstract][Full Text] [Related]
19. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide.
Jonas JB; Akkoyun I; Kamppeter B; Kreissig I; Degenring RF
Eye (Lond); 2005 Jan; 19(1):65-71. PubMed ID: 15105817
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
